A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years

• Asıl Yazarlar: Tino F. Schwarz (Yazar), Li-Min Huang (Yazar), Alejandra Valencia (Yazar), Falko Panzer (Yazar), Cheng-Hsun Chiu (Yazar), Annabelle Decreux (Yazar), Sylviane Poncelet (Yazar), Naveen Karkada (Yazar), Nicolas Folschweiller (Yazar), Lan Lin (Yazar), Gary Dubin (Yazar), Frank Struyf (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2019-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

This study assessed long-term immunogenicity and safety following 3 doses of AS04-adjuvanted human papillomavirus (HPV)-16/18 L1 virus-like particle (VLP) vaccine in females 10-14 years old. Girls included in the immunogenicity subset in the primary controlled, observer-blinded, randomized study (NC...